The lupus therapeutics market exhibits complex segmentation across multiple dimensions including drug class, disease type, distribution channel, and patient demographics. The Lupus Market segment structure reflects the heterogeneity of lupus presentations and therapeutic approaches. Drug class segmentation includes corticosteroids, antimalarials, immunosuppressants, biologics, and emerging...